Evidence map›Paper›PMID 41180932›Full record

ArticleInternational journal of transgender health2025

How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones.

Sarah Warzywoda, James A Fowler, Penny Wood, Fiona Bisshop, Darren Russell, Hemming Luu, Melissa Kelly, Victoria Featherstone, Judith A Dean

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of transgender health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sarah WarzywodaFaculty of Medicine, School of Public Health, The University of Queensland, Herston, QLD, Australia.ORCID https://orcid.org/0000-0002-9149-1962
James A FowlerFaculty of Medicine, School of Public Health, The University of Queensland, Herston, QLD, Australia.ORCID https://orcid.org/0000-0001-5716-5250
Penny WoodAlexander Heights Family Practice, Perth, WA, Australia.
Fiona BisshopHoldsworth House Medical Practice, Brisbane, QLD, Australia.
Darren RussellCairns Sexual Health Service, Cairns, QLD, Australia.
Hemming LuuStonewall Medical Centre, Brisbane, QLD, Australia.
Melissa KellyThe Albion Centre, Sydney, NSW, Australia.
Victoria FeatherstoneHoldsworth House Medical Practice, Brisbane, QLD, Australia.
Judith A DeanFaculty of Medicine, School of Public Health, The University of Queensland, Herston, QLD, Australia.ORCID https://orcid.org/0000-0002-2513-2013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cyproterone acetatefeminizationgender affirming hormone therapytestosteronetransgender

Identifiers

PMID41180932
PMCPMC12573561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.